Cannabis Health/LinkedIn
Mar 9, 2026, 10:16
Ananda Pharma Cleared to Launch Phase 2 Trial for Endometriosis Pain Treatment – Cannabis Health
Cannabis Health shared a post on LinkedIn:
“Ananda Pharma Ltd has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial in women with endometriosis-associated pain.
The company has received approval from the MHRA and NHS Health Research Authority to commence dosing of its proprietary MRX1 CBD oral solution.
Melissa Sturgess, CEO of Ananda Pharma, said: ‘The reason this study is different is that we are using a product that could go all the way through to regulatory approval and be able to be prescribed by a doctor on the NHS.’ ”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 29, 2026, 01:03Seeking a Second Opinion Is Not Being Difficult, It Is a Valid Part of Informed Care – PCOS Awareness Association
-
Jul 29, 2026, 00:57Szabo Gabor: IOTA Day 2026 Advancing Ultrasound in Gynaecological Oncology
-
Jul 29, 2026, 00:55Islam Badr: A Simple Approach to Fetal Heart Screening
-
Jul 29, 2026, 00:50Hardeep Singh: Understanding the Global IVF Travel Landscape
-
Jul 29, 2026, 00:48Asma Khatun: Shaping the Future of Women’s Healthcare at GFWH 2026
-
Jul 29, 2026, 00:43Shaping the Future of Reproductive Medicine at ASRM Innovate – ASRM
-
Jul 29, 2026, 00:37George Condous: Gratitude Makes Every Achievement Greater!
-
Jul 29, 2026, 00:35As AMH Falls, Progesterone May Rise Earlier in Ovarian Stimulation! – Fertility Plus
-
Jul 29, 2026, 00:33An Easy Method for Systematic Fetal Cardiac Screening – ISUOG